Pages that link to "Q72029115"
Jump to navigation
Jump to search
The following pages link to Efficacy and safety of pravastatin in the long-term treatment of elderly patients with hypercholesterolemia (Q72029115):
Displaying 10 items.
- Comparative tolerability of the HMG-CoA reductase inhibitors (Q34045770) (← links)
- Pravastatin: a review of its use in elderly patients (Q35598680) (← links)
- Management strategies of dyslipidemia in the elderly: 2005. (Q36449143) (← links)
- Management of dyslipidemia in the elderly population (Q37802082) (← links)
- Pravastatin. A reappraisal of its pharmacological properties and clinical effectiveness in the management of coronary heart disease (Q41348490) (← links)
- Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in the treatment of patients with hypercholesterolemia: a meta-analysis of clinical trials (Q41648614) (← links)
- Health-related quality of life and long-term therapy with pravastatin and tocopherol (vitamin E) in older adults (Q44186788) (← links)
- Epidemiology of lipid profile of the Spanish elderly population: the EPICARDIAN study (Q44895399) (← links)
- The efficacy and safety of pravastatin in patients aged 60 to 85 years with low-density lipoprotein cholesterol > 160 mg/dl (Q70834600) (← links)
- Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial (Q80720162) (← links)